Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Current State of knowledge on Takotsubo Syndrome: A Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology
2015 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Nasopharyngeal carcinoma
2005 Standout
Universal Definition of Myocardial Infarction: Clinical Insights
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Nuclear imaging in cardiac amyloidosis
2009
Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma
2004
Guideline of transthyretin-related hereditary amyloidosis for clinicians
2013 Standout
Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer
1997
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2017
Atherosclerosis
2019 Standout
2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
99Tcm nanocolloid scintigraphy: a reliable way to detect active joint disease in patients with peripheral joint pain
2001
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.
1997
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Comparison of hepatocellular carcinoma in E astern versus W estern populations
2016
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Works of Anthony Goh being referenced
Bone scintigraphy in nasopharyngeal carcinoma
1990
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma
2016
Stress myocardial perfusion imaging for the evaluation and triage of chest pain in the emergency department: A randomized controlled trial
2013
Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma
2014
99Tcm-polyclonal IgG and 99Tcm nanocolloid scans in orthopaedics
1993
Technetium-99m (Tc-99m) diphosphono-propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis--a case report.
1995
Role of technetium-99m sestamibi in localisation of thyroid cancer metastases.
1993